SARS-CoV-2-specific immune response and the pathogenesis of COVID-19
E Gusev, A Sarapultsev, L Solomatina… - International journal of …, 2022 - mdpi.com
The review aims to consolidate research findings on the molecular mechanisms and
virulence and pathogenicity characteristics of coronavirus disease (COVID-19) causative …
virulence and pathogenicity characteristics of coronavirus disease (COVID-19) causative …
Two years into the COVID-19 pandemic: lessons learned
SJR da Silva, JCF do Nascimento… - ACS infectious …, 2022 - ACS Publications
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible
and virulent human-infecting coronavirus that emerged in late December 2019 in Wuhan …
and virulent human-infecting coronavirus that emerged in late December 2019 in Wuhan …
T cell metabolism in infection
JA Wik, BS Skålhegg - Frontiers in immunology, 2022 - frontiersin.org
T lymphocytes (T cells) are divided into two functionally different subgroups the CD4+ T
helper cells (Th) and the CD8+ cytotoxic T lymphocytes (CTL). Adequate CD4 and CD8 T …
helper cells (Th) and the CD8+ cytotoxic T lymphocytes (CTL). Adequate CD4 and CD8 T …
A global picture: therapeutic perspectives for COVID-19
VP Chavda, C Kapadia, S Soni, R Prajapati… - …, 2022 - Taylor & Francis
The COVID-19 pandemic is a lethal virus outbreak by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), which has severely affected human lives and the global …
coronavirus-2 (SARS-CoV-2), which has severely affected human lives and the global …
Optimization of the SARS-CoV-2 ARTIC network V4 primers and whole genome sequencing protocol
AW Lambisia, KS Mohammed, TO Makori… - Frontiers in …, 2022 - frontiersin.org
Introduction The ARTIC Network's primer set and amplicon-based protocol is one of the most
widely used SARS-CoV-2 sequencing protocol. An update to the V3 primer set was released …
widely used SARS-CoV-2 sequencing protocol. An update to the V3 primer set was released …
Clinical severity of SARS-CoV-2 omicron variant compared with delta among hospitalized COVID-19 patients in Belgium during autumn and winter season 2021 …
N Van Goethem, PYJ Chung, M Meurisse… - Viruses, 2022 - mdpi.com
This retrospective multi-center matched cohort study assessed the risk for severe COVID-19
(combination of severity indicators), intensive care unit (ICU) admission, and in-hospital …
(combination of severity indicators), intensive care unit (ICU) admission, and in-hospital …
[HTML][HTML] Herbal remedies, nutraceuticals, and dietary supplements for COVID-19 management: an update
Currently, the world is facing a Coronavirus pandemic with a grave deficiency of specific
therapy for Coronavirus Disease (COVID-19). Moreover, scientists attempt to discover the …
therapy for Coronavirus Disease (COVID-19). Moreover, scientists attempt to discover the …
SARS-CoV-2 variants and clinical outcomes: a systematic review
IR Mendiola-Pastrana, E Lopez-Ortiz… - Life, 2022 - mdpi.com
Background: From the start of the COVID-19 pandemic, new SARS-CoV-2 variants have
emerged that potentially affect transmissibility, severity, and immune evasion in infected …
emerged that potentially affect transmissibility, severity, and immune evasion in infected …
COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies
Abstract Coronavirus Disease‐19 (COVID‐19) is an infectious disease caused by severe
acute respiratory syndrome‐coronaviruses‐2 (SARS‐CoV‐2), a highly pathogenic and …
acute respiratory syndrome‐coronaviruses‐2 (SARS‐CoV‐2), a highly pathogenic and …
Spike protein mediated membrane fusion during SARS‐CoV‐2 infection
X Li, H Yuan, X Li, H Wang - Journal of Medical Virology, 2023 - Wiley Online Library
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
has posed a serious threat to public health and has quickly become a global concern. The …
has posed a serious threat to public health and has quickly become a global concern. The …